Literature DB >> 19579148

Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan.

Yi-Tsung Lin1, Cheng-Hsun Chiu, Yu-Jiun Chan, Mei-Lin Lin, Kwok-Woon Yu, Fu-Der Wang, Cheng-Yi Liu.   

Abstract

A limited number of reports have documented bacteremia caused by Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) in adults. Most cases have occurred in Taiwan. This study investigated the clinical features and risk factors for mortality from E. meningoseptica bacteremia and the antimicrobial susceptibilities of the isolates. Patients with E. meningoseptica bacteremia were retrospectively analyzed at a medical center/teaching hospital in northern Taiwan over a 3-y period. We analyzed clinical features and outcomes of patients and antimicrobial susceptibilities and pulsed-field gel electrophoresis (PFGE) results of the isolates. 28 patients had nosocomial bacteremia and 4 patients had healthcare associated bacteremia. The isolates exhibited variable susceptibilities to levofloxacin, ciprofloxacin, piperacillin-tazobactam, tigecycline, and trimethoprim-sulfamethoxazole. PFGE demonstrated that most isolates were epidemiologically unrelated. The 28-d mortality rate was 41%. Multivariate analysis indicated that shock and use of inappropriate antibiotics were independent risk factors for mortality. In conclusion, nosocomial bloodstream infection due to E. meningoseptica is an increasing problem in Taiwan. Our study indicates that patients with E. meningoseptica bacteremia face poor prognoses, with shock and use of inappropriate antibiotics as the main risk factors for mortality. Further clinical study is needed to establish the optimal therapy for E. meningoseptica bacteremia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19579148     DOI: 10.1080/00365540903089476

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  18 in total

1.  Risk factors and outcome of levofloxacin-resistant Elizabethkingia meningoseptica bacteraemia in adult patients in Taiwan.

Authors:  Y-C Huang; Y-W Huang; Y-T Lin; F-D Wang; Y-J Chan; T-C Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-07       Impact factor: 3.267

2.  Occurrence of antimicrobial resistance genes sul and dfrA12 in hospital environmental isolates of Elizabethkingia meningoseptica.

Authors:  Xiaobing Jiang; Dapeng Wang; Yuxiao Wang; He Yan; Lei Shi; Lijun Zhou
Journal:  World J Microbiol Biotechnol       Date:  2012-07-10       Impact factor: 3.312

3.  Relative Prevalence and Antimicrobial Susceptibility of Clinical Isolates of Elizabethkingia Species Based on 16S rRNA Gene Sequencing.

Authors:  Mi-Soon Han; Hyunsoo Kim; Yangsoon Lee; Myungsook Kim; Nam Su Ku; Jun Yong Choi; Dongeun Yong; Seok Hoon Jeong; Kyungwon Lee; Yunsop Chong
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

Review 4.  Septic shock caused by Elizabethkingia meningoseptica: a case report and review of literature.

Authors:  Su Hyeon Jung; Boeun Lee; Aibek E Mirrakhimov; Nasir Hussain
Journal:  BMJ Case Rep       Date:  2013-04-03

5.  Multidrug resistant Elizabethkingia meningoseptica bacteremia - Experience from a level 1 trauma centre in India.

Authors:  Aishwarya Govindaswamy; Vijeta Bajpai; Vivek Trikha; Samarth Mittal; Rajesh Malhotra; Purva Mathur
Journal:  Intractable Rare Dis Res       Date:  2018-08

6.  Elizabethkingia Meningoseptica Engodenous Endophthalmitis - a case report.

Authors:  Stephanie Ming Young; Gopal Lingam; Paul Anantharajah Tambyah
Journal:  Antimicrob Resist Infect Control       Date:  2014-11-26       Impact factor: 4.887

Review 7.  Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis.

Authors:  Gowri Raman; Esther Avendano; Samantha Berger; Vandana Menon
Journal:  BMC Infect Dis       Date:  2015-09-30       Impact factor: 3.090

8.  Elizabethkingia meningoseptica bacteremia in immunocompromised hosts: The first case series from India.

Authors:  Abdul Ghafur; P R Vidyalakshmi; K Priyadarshini; Jose M Easow; Revathi Raj; T Raja
Journal:  South Asian J Cancer       Date:  2013-10

9.  Risk Factors for Elizabethkingia Acquisition and Clinical Characteristics of Patients, South Korea.

Authors:  Min Hyuk Choi; Myungsook Kim; Su Jin Jeong; Jun Yong Choi; In-Yong Lee; Tai-Soon Yong; Dongeun Yong; Seok Hoon Jeong; Kyungwon Lee
Journal:  Emerg Infect Dis       Date:  2019-01       Impact factor: 6.883

10.  Elizabethkingia meningosepticum in a Patient with Six-Year Bilateral Perma-Catheters.

Authors:  Konstantin Boroda; Li Li
Journal:  Case Rep Infect Dis       Date:  2014-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.